SCHEMBL15520375

SCHEMBL15520375

CC(C)Cc1cc(O)cc(C(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.54
CA1 P00915 3/20 0.54
CA2 P00918 3/20 0.54
CA9 Q16790 3/20 0.54
CA7 P43166 2/20 0.54
CA14 Q9ULX7 2/20 0.54
HCAR1 Q9BXC0 3/20 0.50
PTGS1 P23219 3/20 0.41
PTGS2 P35354 3/20 0.41
LMNA P02545 2/20 0.41
CYP2C9 P11712 2/20 0.41
AKR1C3 P42330 2/20 0.41
CXCR1 P25024 2/20 0.41
CXCR2 P25025 2/20 0.41
AKR1C2 P52895 2/20 0.41
ALB P02768 1/20 0.41
ESR1 P03372 1/20 0.41
ALOX5 P09917 1/20 0.41
RARB P10826 1/20 0.41
ADRB3 P13945 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16653943 0.88 PTGS1 (0.46) CA12CA1CA2CA9CA7
SCHEMBL1355428 0.88 PTGS1 (0.46) CA12CA1CA2CA9CA7
SCHEMBL17756315 0.81 TPMT (0.57) HCAR1PTGS1PTGS2LMNACYP2C9
SCHEMBL2319081 0.81 CA12 (0.61) CA12CA1CA2CA9CA7
SCHEMBL2723874 0.80 TPMT (0.41) PTGS1PTGS2LMNACYP2C9AKR1C3
SCHEMBL25403702 0.80 GRIN2D (0.56) CA12CA1CA2CA9CA7
SCHEMBL4968027 0.80 GABRA1 (0.48) PTGS1PTGS2LMNACYP2C9AKR1C3
SCHEMBL6442439 0.80 GABRA1 (0.48) PTGS1PTGS2LMNACYP2C9AKR1C3
SCHEMBL27811020 0.79 CA12 (0.50) CA12CA1CA2CA9CA7
SCHEMBL10952902 0.79 CA12 (0.60) CA12CA1CA2CA9CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2185570-B1 NOVEL ACTIVATORS OF GLUCOKINASE METABASIS THERAPEUTICS INC (US) 2014-03-19 EP disclosed